The Food and Drug Administration (FDA) and AS Medications Solutions LLC announced a nationwide recall of all lots of the 0.25 mg. heart medication digoxin manufactured by Caraco Pharmaceuticals Laboratories distributed prior to March 31, 2009 because they may differ in size and therefore may contain more or less of the active ingredient.

This action follows an alert issued by the company for the Caraco brand Digoxin, USP, 0.125 mg and the Digoxin, USP, 0.25 mg tablets, both distributed prior to 2009. That recall included both 100-count and 1,000-count tablets of both mgs. The latest recall adds the 20-count 0.25 mg tablet to the recall.

Product included in the recall NDC numbers are:

Digoxin Tablets, USP, 0.125 mg
57664-437-88 (100-count)
57664-437-18 (1000-count)

Digoxin Tablets, USP, 0.25 mg
57664-441-88 (100-count)
57664-441-18 (1000-count)

Digoxin is used to treat heart failure and abnormal heart rhythms. A higher than labeled dose may pose a risk of digoxin toxicity in patients with renal failure. Digoxin toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia and death. A lower than labeled dose may pose a risk of lack of efficacy potentially resulting in cardiac instability.

Last year, Actavis Totowa LLC, a generic pharmaceutical company initiated a Class 1 recall on Digitek brand digoxin tablets when it was learned that some tablets were oversized and contained twice the level of active ingredient, putting consumers at risk.

Consumers of Caraco’s digoxin tablets that fall within the recall should return these products to their pharmacy or place of purchase. Patients who have medical questions should contact their health care provider for additional instructions or guidance.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

ETHEX expands voluntary recall

ETHEX Corporation has expanded two previous voluntary recalls initially issued in 2008 to include more...

Chad Cook on the Digitek recall

Chad Cook, lead Digitek attorney, speaks about the recent Digitek recall. Digitek was recalled in April...

Digitek

What is Digitek? Digoxin is a medication used to treat congestive heart failure, abnormal heart rhythms...

Double-strength digoxin recalled in U.S.

A heart medication sold by Mylan Laboratories in the US has had to be recalled, after it emerged that...

Extent of Digitek recall remains a mystery 10 days...

News about the April 2008 Digitek recall came first in the form of a brief company press release dated...

Extra ingredients prompt Digitek digoxin recall

The fact that the heart failure treatment drug Digitek (Digoxin) may contain twice the approved level of...

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip